Attorney Pages - Help you find the right lawyers and law firms.
 
 
 
 
PRINT
EMAIL
  
A
A
  
 
 
Home » Hot Topics » Heparin Recall » Baxter’s Heparin Issues Continue: FDA Admits Never Inspecting Chinese Manufacturer

Heparin Recall

Article: Baxter’s Heparin Issues Continue: FDA Admits Never Inspecting Chinese Manufacturer

Free Case Evaluation


Additional details about Baxter Healthcare Corporation’s, urgent recall of Heparin, a prescription injectable blood coagulant often used in hemodialysis (the filtering of blood) and cardiac invasive procedures, on January 25th 2008 are now being released. The Food and Drug Administration (FDA) has reported that it never inspected the Chinese manufacturing plant that provides Baxter with the active ingredient of the drug.

FDA admission

According to several news sources, the FDA, already under scrutiny for not adequately protecting the public against many harmful drugs and defective medical devices, admitted that it did not inspect the Chinese plant that provides Baxter with Heparin’s active ingredient – an enzyme taken from pig intestines – which has been linked to several adverse reactions to the drug.

The active ingredient is shipped to a Baxter facility in New Jersey where the final manufacturing process is completed. Baxter has reported that it inspected the plant outside of Shanghai, China less than months beforehand and that it plans to inspect it again based on this latest report.

Products affected by the recall

The recall affects the following products:

  • Heparin 1,000 Units/ML 10 and 30mL Multi-Dose Vials
  • NDC (National Drug Code) NUMBERS 0641-2440-45, 0641-2440-41, 0641-2450-45 and 0641-2450-41
  • LOTS: 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074, 107111

Symptoms associated with the drug

Baxter has advised that the following symptoms may be associated with the drug – some of which may be life threatening:

Discomfort, vomiting, diarrhea, decreased or low blood pressure, chest and stomach pain, fast heart rate, dizziness, fainting, unresponsiveness, nausea, shortness of breath, feeling your heart beat strong or fast, drug ineffectiveness, burning sensation, redness or paleness of skin, abnormal sensation of the skin, mouth or lips, flushing, increased sweating, decreased skin sensitivity, headache, feeling unwell, restlessness, watery eyes, throat swelling, thirst and difficulty opening the mouth.

If you’ve been injured due to Heparin use, contact an attorney to discuss your situation. The consultation is free and without obligation. To contact a qualified attorney whose practice focuses in this area of law, please click here.

Articles & Information:

AM2 PAT, Inc. Recalls Heparin and Normal Saline Pre-Filled Flushes

Baxter Healthcare Recalls 9 Lots of Heparin

Where Raw Heparin Comes From: A Picture Is Worth a 1,000 Words

Baxter Heparin Recalls ALL Remaining Lots: FDA Links 17 More Deaths to Drug

Heparin Litigation: Likely Causes of Action

Heparin: What Injuries Have Been Reported?

Heparin Litigation: Statute Of Limitations

Heparin: How Much Do You Know?

Unknown Heparin Contaminant Baffles FDA

FDA Halts Imported Heparin

B. Braun Medical & American Health Packaging Recall More Heparin

Italy, France, Denmark & Australia Recall Heparin

Japanese Companies & Germany Heparin Recall

Covidien Recalls 32 Lots of Heparin

FDA Now Says Heparin Deaths Are 30% Higher Than Originally Reported

FDA Says Fraud Involved In U.S. Heparin Supply

FDA Now Says 81 Deaths Linked To Heparin Contamination

Is Praxada An Alternative To Heparin?

Ohio Man Loses Wife and Son Due To Contaminated Heparin

Dennis Quaid Files Lawsuit against Baxter International over Heparin Labeling

Baxter Sued Over Contaminated Heparin That May Have Killed TX Woman

Heparin Lawsuits Will Be Heard In Toledo Ohio

Two Texas Infants Die from Alleged Heparin Overdose

FDA Now Able To Link Heparin Lots to Deaths